Prolonged Enoxaparin in Primary Percutaneous Coronary Intervention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03568838

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03568838
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03568838. Randomized; no masking; primary purpose prevention. Start 2018-06-28 (actual); primary completion 2020-05-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prolonged Enoxaparin in Primary Percutaneous Coronary Intervention
Acronym
PENNYWISE
Intervention (Drug)
Enoxaparin
Lead sponsor
Sheffield Teaching Hospitals NHS Foundation Trust (class: other)
Collaborator
Medical Research Council (class: other government)

Record details

Record id
cardio:ct-nct03568838
Content hash
dcb6fbe4a9547b9857764af426d752394091601c56d5132bf23ab8d9b7d9a1de